PFBT
VIR icon

Parkside Financial Bank & Trust’s Vir Biotechnology VIR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408 Hold
40
– – ﹤0.01% 2626
2026
Q1 		$359 Hold
40
– – ﹤0.01% 2604
2025
Q4 		$242 Hold
40
– – ﹤0.01% 2628
2025
Q3 		$229 Sell
40
-23
-37% -$118 ﹤0.01% 2652
2025
Q2 		$318 Sell
63
-29
-32% -$155 ﹤0.01% 2637
2025
Q1 		$597 Buy
92
+56
+156% +$498 ﹤0.01% 2288
2024
Q4 		$265 Hold
36
– – ﹤0.01% 2008
2024
Q3 		$270 Sell
36
-3
-8% -$26 ﹤0.01% 1956
2024
Q2 		$348 Hold
39
– – ﹤0.01% 1846
2024
Q1 		$396 Hold
39
– – ﹤0.01% 1801
2023
Q4 		$393 Sell
39
-682
-95% -$6.23K ﹤0.01% 1800
2023
Q3 		$6.76K Buy
721
+514
+248% +$7.33K ﹤0.01% 1257
2023
Q2 		$5.08K Sell
207
-276
-57% -$6.93K ﹤0.01% 1362
2023
Q1 		$11.2K Buy
483
+8
+2% +$205 ﹤0.01% 1063
2022
Q4 		$12K Buy
475
+142
+43% +$3.48K ﹤0.01% 1003
2022
Q3 		$6K Buy
333
+63
+23% +$1.6K ﹤0.01% 1180
2022
Q2 		$7K Buy
+270
New +$6.3K ﹤0.01% 1131

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parkside Financial Bank & Trust's VIR Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Vir Biotechnology (VIR) position steady in Q2 2026 at 40 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

Parkside Financial Bank & Trust first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $12K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Parkside Financial Bank & Trust held 40 shares of Vir Biotechnology worth $408 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2626 holding.
  • Parkside Financial Bank & Trust first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Parkside Financial Bank & Trust's Vir Biotechnology position peaked at $12K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.